PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-10-02

Date Title Company
02-Oct-2021 Kyowa Kirin and Amgen Present Positive Late-Breaking Data from Phase 2 Study of KHK4083/AMG 451 in Adult Patients with Moderate-to-Severe Atopic Dermatitis at EADV Congress Businesswire